<DOC>
	<DOCNO>NCT02264587</DOCNO>
	<brief_summary>The purpose study evaluate effect mechanism mosapride citrate diabetic gastroparesi .</brief_summary>
	<brief_title>Effects Mechanism Mosapride Citrate Diabetic Gastroparesis</brief_title>
	<detailed_description>To evaluate effect mosapride DPG 13 C - octylic acid breath test . IF C13- octylic acid absorb mucous membrane small intestine , octylic acid oxidate CO2.Patients eat food contain C13 , collect expire gas 15 , 30,45,60,75,90,105,120,150,180,210,240min , analyse mass C13 mass spectrometer , calculate gastric empty rate .</detailed_description>
	<mesh_term>Gastroparesis</mesh_term>
	<mesh_term>Domperidone</mesh_term>
	<mesh_term>Mosapride</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>1 . 18≤ age ≤ 75 2 . Patients coincide , WHO diagnostic criterion diabetes 1999 ( namely diabetes symptom , plasma glucose tendency 11.1 / L , time fast plasma glucose tendency 7.0 / L , oral glucose tolerance test 2 h plasma glucose level tendency 11.1 / L） 3. fast bloodglucose≤7.0mmol/L 2h postprandial plasma glucose≤10.0mmol/L 4 . Be diagnose diabetes 5 year , blood sugar steady one month . 5. follow symptom 4weeks : early satiety , postprandial fullness , nausea , vomting , abdominal distension , belching , inappetence , epigastric pain , constipation . 6 . Be diagnose Delayed Gastric Emptying C13 breath test . 7 . Signed informed consent . 1. take gastrointestinal drug within 2 week prior screen . Or patient digestive disease . 2 . All patient administrate gastroscope order exclude stomach duodenum disease , pyloric obstruction . It 's normal Liver , gallbladder , pancreas , spleen , nephridium Ultrasound examination . 3 . Serious ketoacidosis . 4 . History abdominal operation . 5 . Thyroid hypofunction hyperthyroidism . 6. nervous system disease autoimmune disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>